What foods can I eat while on Semaglutide weight loss treatment
The trial currently has almost 10,000 patients enrolled and is expected to assess a composite MACE endpoint consisting of cardiovascular (CV) death, non-fatal myocardial infarction, or non-fatal stroke in patients with T2D as is expected to readout in July 2024 (NCT03574597)
4 Discussion In this exploratory post hoc analysis of a pilot trial, we aimed to study the effect of GLP1Ra-based therapy on measures of bone health in older adults with overweight or obesity
Back Gilbert, B, Rosenthal, D (21 Jan 2024) 'The complete history & strategy of Novo Nordisk: Novo Nordisk (Ozempic)', Acquired podcast, Season 14, Episode 1
Obesity and endothelial function